NCT05970367Completed
Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease
Impact of an Intensive Motor Rehabilitation Programme Integrating Technology for Adults With Central Neurological Disease: A Randomised Controlled Rehabilitation Study in the Chronic Phase
Source: ClinicalTrials.gov · Last updated 9 Jan 2026
Brief summary (registry, in English)
This project will consist of 1 large clinical trial with 3 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs and benefits; (3) process evaluation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 102 (actual)
- First submitted
- 23 Jun 2023
- Start date
- 10 Jul 2023
- Primary completion date
- 9 Jul 2025
- Lead sponsor
- KU Leuven
- Diseases
- Stroke
- NCT number
- NCT05970367
What you commit to
- Study type: Interventional
- Participants enrolled: 102
- From 10 Jul 2023 to the primary completion date, 9 Jul 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having other neurological or musculoskeletal conditions that may affect the protocol, assessed by a specialist;
- Severe visual impairment, communication, cognitive and language formation problems that would prevent the intervention and measurement process, assessed by a specialist;
- Any disorder, which in the investigator's opinion might the compromise participant's safety or compliance with the CIP;
Other
- No ability to initiate movements against gravity in the upper and lower limbs;
- Female who is pregnant, breast-feeding.
Who the study is looking for
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures;
- A diagnosis of central neurological disease, made by a specialist. Conditions may include stroke or spinal cord injury:
- Stroke: Participants must have received a diagnosis of stroke for the first time, have been diagnosed at least 3 months ago, and live at home.
- SCI: Participants have a rating A, B, C or D on the American Spinal Injury Association (ASIA) measurement scale, which refers to patients with complete or incomplete impairment. All levels of SCI can be included, if there is a clear patient need linked to the upper and/or lower extremities.
- At least 3 months post discharge from hospital/rehabilitation centre, living at home;
- Having a maximum recovery of 85% of independence in daily functioning (FIM/SCIM);
- Had a normal functional state prior to the pathology: a pre-pathology Barthel Index \> 85/100;
- Unilateral or bilateral weakness of the affected upper or lower limbs (No maximum score in all affected limbs = motricity index: score 5 on 3/3 segments)
- Having the clinical opportunity to engage in exercise therapy with available technology, assessed by a specialist;
- Age of \> 18 years;
- Sufficient cognitive ability to understand the games and give informed consent, assessed by a specialist;.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AZ Herentals Coordinator of this site? Confirm its status | Herentals | Belgium | Unknown status |
| KU Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.